Lumithera: LIGHTSITE III Pivotal Trial 24-Month Analysis: Multiwavelength Valeda® Light Delivery System Treatment in Early/Intermediate Dry Age-Related Macular Degeneration Patients
Location: Emerald Room
Date & Time: Saturday, 7 October, 13:00 - 14:00 CEST
Chairperson(s): Quan Dong Nguyen USA
Speakers:
Presentations:
V. Gonzalez USA
13:00 LIGHTSITE III 24-Month Analysis: Clinical Outcomes
M. Munk SWITZERLAND
13:10 LIGHTSITE III 24-Month Analysis: Imaging Outcomes
Ø.A Utheim NORWAY
13:20 Case Studies: Real World Results of PBM in Dry AMD Patients
